Community Research and Development Information Service - CORDIS

FP6

ANGIOSTOP

Project reference: 37386
Funded under: FP6-LIFESCIHEALTH

Novel anti-angiogenic treatment for cancer, arthritis and ocular neo-vascularization based on inhibition of Placental Growth Factor (PlGF) [Print to PDF] [Print to RTF]

From 2006-06-01 to 2009-05-31 | ANGIOSTOP Website

Project details

Total cost:

EUR 5 146 847

EU contribution:

EUR 1 993 208

Coordinated in:

Sweden

Call for proposal:

FP6-2005-LIFESCIHEALTH-7

Funding scheme:

STREP - Specific Targeted Research Project

Objective

Related information

Open Access

Coordinator

BIOINVENT INTERNATIONAL AB (PLC)
Sweden
Sölvegatan 41
LUND, Sweden
Administrative contact: Titti NISKANEN
Tel.: +46-462868550
Fax: +46-462110806
E-mail

Participants

THROMBOGENICS LIMITED
Ireland
14 Bridgecourt Office Park, Walkinston Avenue
DUBLIN, Ireland
Administrative contact: Jean Marie STASSEN
Tel.: +32-16345772
Fax: +32-16345990
FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW
Belgium
Rijvisschestraat 120
ZWIJNAARDE, Belgium
Administrative contact: Peter CARMELIET
Tel.: +32-016345775
Fax: +32-016345990
E-mail
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium
Oude Markt 13
LEUVEN, Belgium
Administrative contact: Eric VANCUTSEM
Tel.: +32-16344218
Fax: +32-163444419
E-mail
CARDIFF UNIVERSITY
United Kingdom
30-36 Newport Road
CARDIFF, United Kingdom
Administrative contact: Wen JIANG
Tel.: +44-02920742895/2896
Fax: +44-02920761623
E-mail
CHARITÉ, UNIVERSITAETSMEDIZIN BERLIN, CAMPUS VIRCHOW-KLINIKUM, MEDIZINISCHE KLINIK MIT SCHWERPUNKT HEPATOLOGIE UND GASTROENTEROLOGIE
Germany
Augustenburger Platz 1
BERLIN, Germany
Administrative contact: Christian FISCHER
Tel.: +32-16345772
Fax: +32-16345990
Record Number: 84975 / Last updated on: 2013-03-26